Novo Integrated Sciences CEO Robert Mattacchione resigns effective Feb 5, 2025; remains Chairman

Novo Integrated Sciences, Inc.

CEO Robert Mattacchione resigned effective February 5, 2025, following a 90-day transition period.
Resignation was not due to any disagreement with the company on operations, policies, or practices.
He will continue as Chairman of the Board and Chairman of Novo Healthnet Limited, a wholly owned subsidiary.
He remains a director nominee for election at the annual meeting on November 22, 2024.

item 5.02 item 8.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Robert Mattacchione

Chief Executive Officer

Novo Integrated Sciences, Inc.

Effective: 2025-02-05
Filed: November 14, 2024, 6:59 PM ET

On November 7, 2024, Robert Mattacchione resigned as Chief Executive Officer of Novo Integrated Sciences, Inc. (the “Company”), effective 90 days following the notification date (i.e. effective February 5, 2025).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert Mattacchione resigned as Chief Executive Officer at Novo Integrated Sciences, Inc..

Action: resigned
Role: Chief Executive Officer

Exact text from the filing

On November 7, 2024, Robert Mattacchione resigned as Chief Executive Officer of Novo Integrated Sciences, Inc. (the “Company”), effective 90 days following the notification date (i.e. effective February 5, 2025).

View on SEC.gov

Source: SEC EDGAR

accession 0001493152-24-045968

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.